Abiopharma

🔍 Mazzacco Catherine (Executive)

Company: Sight Sciences, Inc. (SGHT)

Report Date: 2025-06-05

Detailed Transactions and Holdings:

• Acquired 30,952 shares of Common Stock (Direct)
  Date: 2025-06-05 | Code: A | equity_swap_involved: false | shares_owned_after: 78,507.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 5, 2025. The RSUs vest on the earlier of June 5, 2026 and the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
• F2: Includes (i) 37,492 shares of Common Stock, (ii) 30,952 RSUs which are subject to vesting as reported herein, and (iii) 10,063 RSUs granted to the Reporting Person on June 8, 2023 which are subject to vesting as previously reported.